Back to trial

NCT01033032

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Version 16 to 17 · SCRI Development Innovations, LLC

Patch inspector

Version 16 to 17

412 operations 7 path groups ctgov_internal_history
ClinicalTrials.gov
Severity is deterministic uncalibrated triage metadata, not validated review priority. Operation-level severity is inferred from deterministic path rules. Rule matches shown per operation are approximate previews (they skip the pipeline's suppression passes); the authoritative classification is the stored event record.
Plain-language summary

Manual review pending.

Rules fired
adverse_event_group_changearms_or_interventions_changeother_adverse_event_additionother_adverse_event_modificationserious_adverse_event_additionserious_adverse_event_modification
Value signals
[
  {
    "paths": [
      "/protocolSection/outcomesModule/primaryOutcomes/0/description",
      "/protocolSection/outcomesModule/primaryOutcomes/0/measure",
      "/protocolSection/outcomesModule/secondaryOutcomes/0/description",
      "/protocolSection/outcomesModule/secondaryOutcomes/0/timeFrame",
      "/protocolSection/outcomesModule/secondaryOutcomes/1/description",
      "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
      "/protocolSection/outcomesModule/secondaryOutcomes/1/timeFrame",
      "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
      "/protocolSection/outcomesModule/secondaryOutcomes/2/timeFrame"
    ],
    "signal": "results_reconciliation_outcome_suppression",
    "category": "results_reconciliation",
    "severity": "low"
  }
]
Provenance
Source
ctgov_internal_history
Fetched
2026-06-18 18:59:43+00
Raw hash
b04f904b6ece81bb2ee7685792c7fba064c66c4ca90558fb9e2ff8fc8880b053
Payload
Source URL
Primary outcomes Outcome measures that define the trial's primary evidence target. Triage: Critical 2 ops
replace /protocolSection/outcomesModule/primaryOutcomes/0/measure
Triage: Critical
Primary Outcome Change Operation 7
Matched rules
  • primary_outcome_any_change Any add/remove/replace under primary outcome measures is critical review priority.
Before
Progression-free Survival (PFS)
After
Progression-Free Survival (PFS) of MTD/Phase II Patients
replace /protocolSection/outcomesModule/primaryOutcomes/0/description
Triage: Critical
Primary Outcome Change Operation 8
Matched rules
  • primary_outcome_any_change Any add/remove/replace under primary outcome measures is critical review priority.
Before
Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on study.
Progression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions
After
Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.
Progression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
Adverse events and safety Posted serious or other adverse event data. Triage: High 295 ops
replace /resultsSection/adverseEventsModule/description
Triage: Uncategorized
Uncategorized Operation 118
Before
Adverse Event analysis includes only patients treated at the MTD (Dose Level 3)
After
All patients who received at least one dose of protocol treatment were followed for safety.
Adverse events and serious adverse events were collected from the day of the first dose to 30 days after the last dose of the study medication and graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0
replace /resultsSection/adverseEventsModule/eventGroups/0/title
Triage: High
Adverse Event Group Change Operation 119
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
Dose Level 3
After
Dose Level 1
replace /resultsSection/adverseEventsModule/eventGroups/0/description
Triage: High
Adverse Event Group Change Operation 120
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
Includes patients treated at the MTD (Dose Level 3)
After
Amrubicin - 90 mg/m^2 by intravenous (IV) every 21 days
replace /resultsSection/adverseEventsModule/eventGroups/0/seriousNumAffected
Triage: High
Adverse Event Group Change Operation 121
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
5
After
1
replace /resultsSection/adverseEventsModule/eventGroups/0/seriousNumAtRisk
Triage: High
Adverse Event Group Change Operation 122
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
66
After
3
replace /resultsSection/adverseEventsModule/eventGroups/0/otherNumAffected
Triage: High
Adverse Event Group Change Operation 123
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
65
After
3
replace /resultsSection/adverseEventsModule/eventGroups/0/otherNumAtRisk
Triage: High
Adverse Event Group Change Operation 124
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/eventGroups/1
Triage: High
Adverse Event Group Change Operation 125
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
After
{
  "id": "EG001",
  "title": "Dose Level 2",
  "description": "Amrubicin - 100 mg/m^2 by intravenous (IV) every 21 days",
  "otherNumAtRisk": 3,
  "otherNumAffected": 3,
  "seriousNumAtRisk": 3,
  "seriousNumAffected": 0
}
add /resultsSection/adverseEventsModule/eventGroups/2
Triage: High
Adverse Event Group Change Operation 126
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
After
{
  "id": "EG002",
  "title": "Dose Level 3 (MTD)/Phase II",
  "description": "Amrubicin - 110 mg/m^2 by intravenous (IV) every 21 days Includes patients treated at the MTD in Dose Level 3 phase 1 and in phase II",
  "otherNumAtRisk": 66,
  "otherNumAffected": 65,
  "seriousNumAtRisk": 66,
  "seriousNumAffected": 5
}
add /resultsSection/adverseEventsModule/eventGroups/3
Triage: High
Adverse Event Group Change Operation 127
Matched rules
  • adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority.
After
{
  "id": "EG003",
  "title": "Dose Level 4",
  "description": "Amrubicin - 120 mg/m^2 by intravenous (IV) every 21 days",
  "otherNumAtRisk": 6,
  "otherNumAffected": 6,
  "seriousNumAtRisk": 6,
  "seriousNumAffected": 1
}
replace /resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 128
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 129
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 130
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/0/stats/1
Triage: High
Serious Adverse Event Addition Operation 131
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/0/stats/2
Triage: High
Serious Adverse Event Addition Operation 132
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/0/stats/3
Triage: High
Serious Adverse Event Addition Operation 133
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 134
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 135
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 136
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/1/stats/1
Triage: High
Serious Adverse Event Addition Operation 137
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/1/stats/2
Triage: High
Serious Adverse Event Addition Operation 138
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/1/stats/3
Triage: High
Serious Adverse Event Addition Operation 139
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 140
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 141
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 142
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/2/stats/1
Triage: High
Serious Adverse Event Addition Operation 143
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/2/stats/2
Triage: High
Serious Adverse Event Addition Operation 144
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/2/stats/3
Triage: High
Serious Adverse Event Addition Operation 145
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 146
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 147
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 148
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/3/stats/1
Triage: High
Serious Adverse Event Addition Operation 149
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/3/stats/2
Triage: High
Serious Adverse Event Addition Operation 150
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/3/stats/3
Triage: High
Serious Adverse Event Addition Operation 151
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 152
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 153
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 154
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/4/stats/1
Triage: High
Serious Adverse Event Addition Operation 155
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/4/stats/2
Triage: High
Serious Adverse Event Addition Operation 156
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/4/stats/3
Triage: High
Serious Adverse Event Addition Operation 157
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/seriousEvents/5/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 158
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/5/stats/1
Triage: High
Serious Adverse Event Addition Operation 159
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/5/stats/2
Triage: High
Serious Adverse Event Addition Operation 160
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/5/stats/3
Triage: High
Serious Adverse Event Addition Operation 161
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numEvents
Triage: High
Serious Adverse Event Modification Operation 162
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAffected
Triage: High
Serious Adverse Event Modification Operation 163
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
1
After
0
replace /resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAtRisk
Triage: High
Serious Adverse Event Modification Operation 164
Matched rules
  • serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/seriousEvents/6/stats/1
Triage: High
Serious Adverse Event Addition Operation 165
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/6/stats/2
Triage: High
Serious Adverse Event Addition Operation 166
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/seriousEvents/6/stats/3
Triage: High
Serious Adverse Event Addition Operation 167
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/seriousEvents/7
Triage: High
Serious Adverse Event Addition Operation 168
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "term": "NEUTROPHIL COUNT DECREASED",
  "stats": [
    {
      "groupId": "EG000",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  ],
  "organSystem": "Blood and lymphatic system disorders",
  "assessmentType": "SYSTEMATIC_ASSESSMENT",
  "sourceVocabulary": "CTCAE v 4.0"
}
add /resultsSection/adverseEventsModule/seriousEvents/8
Triage: High
Serious Adverse Event Addition Operation 169
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "term": "THROMBOCYTOPENIA",
  "stats": [
    {
      "groupId": "EG000",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 2,
      "numAffected": 1
    },
    {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  ],
  "organSystem": "Blood and lymphatic system disorders",
  "assessmentType": "SYSTEMATIC_ASSESSMENT",
  "sourceVocabulary": "CTCAE v 4.0"
}
add /resultsSection/adverseEventsModule/seriousEvents/9
Triage: High
Serious Adverse Event Addition Operation 170
Matched rules
  • serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority.
After
{
  "term": "PULMONARY INFILTERATES",
  "stats": [
    {
      "groupId": "EG000",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  ],
  "organSystem": "Respiratory, thoracic and mediastinal disorders",
  "assessmentType": "SYSTEMATIC_ASSESSMENT",
  "sourceVocabulary": "CTCAE v 4.0"
}
replace /resultsSection/adverseEventsModule/otherEvents/0/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 171
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 172
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 173
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/0/stats/1
Triage: Medium
Other Adverse Event Addition Operation 174
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/0/stats/2
Triage: Medium
Other Adverse Event Addition Operation 175
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 9,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/0/stats/3
Triage: Medium
Other Adverse Event Addition Operation 176
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/1/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 177
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
17
After
0
replace /resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 178
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
6
After
0
replace /resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 179
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/1/stats/1
Triage: Medium
Other Adverse Event Addition Operation 180
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/1/stats/2
Triage: Medium
Other Adverse Event Addition Operation 181
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 17,
  "numAffected": 6
}
add /resultsSection/adverseEventsModule/otherEvents/1/stats/3
Triage: Medium
Other Adverse Event Addition Operation 182
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/2/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 183
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
39
After
0
replace /resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 184
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
8
After
0
replace /resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 185
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/2/stats/1
Triage: Medium
Other Adverse Event Addition Operation 186
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/2/stats/2
Triage: Medium
Other Adverse Event Addition Operation 187
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 39,
  "numAffected": 8
}
add /resultsSection/adverseEventsModule/otherEvents/2/stats/3
Triage: Medium
Other Adverse Event Addition Operation 188
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/3/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 189
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
126
After
6
replace /resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 190
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
32
After
2
replace /resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 191
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/3/stats/1
Triage: Medium
Other Adverse Event Addition Operation 192
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/3/stats/2
Triage: Medium
Other Adverse Event Addition Operation 193
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 126,
  "numAffected": 32
}
add /resultsSection/adverseEventsModule/otherEvents/3/stats/3
Triage: Medium
Other Adverse Event Addition Operation 194
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 6,
  "numAffected": 3
}
replace /resultsSection/adverseEventsModule/otherEvents/4/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 195
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
130
After
7
replace /resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 196
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
27
After
1
replace /resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 197
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/4/stats/1
Triage: Medium
Other Adverse Event Addition Operation 198
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 12,
  "numAffected": 3
}
add /resultsSection/adverseEventsModule/otherEvents/4/stats/2
Triage: Medium
Other Adverse Event Addition Operation 199
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 130,
  "numAffected": 27
}
add /resultsSection/adverseEventsModule/otherEvents/4/stats/3
Triage: Medium
Other Adverse Event Addition Operation 200
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 5,
  "numAffected": 3
}
replace /resultsSection/adverseEventsModule/otherEvents/5/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 201
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
40
After
0
replace /resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 202
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
21
After
0
replace /resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 203
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/5/stats/1
Triage: Medium
Other Adverse Event Addition Operation 204
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 7,
  "numAffected": 2
}
add /resultsSection/adverseEventsModule/otherEvents/5/stats/2
Triage: Medium
Other Adverse Event Addition Operation 205
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 40,
  "numAffected": 21
}
add /resultsSection/adverseEventsModule/otherEvents/5/stats/3
Triage: Medium
Other Adverse Event Addition Operation 206
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 5,
  "numAffected": 3
}
replace /resultsSection/adverseEventsModule/otherEvents/6/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 207
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
7
After
0
replace /resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 208
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 209
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/6/stats/1
Triage: Medium
Other Adverse Event Addition Operation 210
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/6/stats/2
Triage: Medium
Other Adverse Event Addition Operation 211
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 7,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/6/stats/3
Triage: Medium
Other Adverse Event Addition Operation 212
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 2,
  "numAffected": 2
}
replace /resultsSection/adverseEventsModule/otherEvents/7/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 213
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
39
After
0
replace /resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 214
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
14
After
0
replace /resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 215
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/7/stats/1
Triage: Medium
Other Adverse Event Addition Operation 216
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/7/stats/2
Triage: Medium
Other Adverse Event Addition Operation 217
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 39,
  "numAffected": 14
}
add /resultsSection/adverseEventsModule/otherEvents/7/stats/3
Triage: Medium
Other Adverse Event Addition Operation 218
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/8/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 219
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
12
After
0
replace /resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 220
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
6
After
0
replace /resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 221
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/8/stats/1
Triage: Medium
Other Adverse Event Addition Operation 222
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/8/stats/2
Triage: Medium
Other Adverse Event Addition Operation 223
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 12,
  "numAffected": 6
}
add /resultsSection/adverseEventsModule/otherEvents/8/stats/3
Triage: Medium
Other Adverse Event Addition Operation 224
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/9/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 225
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
16
After
0
replace /resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 226
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
8
After
0
replace /resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 227
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/9/stats/1
Triage: Medium
Other Adverse Event Addition Operation 228
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/9/stats/2
Triage: Medium
Other Adverse Event Addition Operation 229
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 16,
  "numAffected": 8
}
add /resultsSection/adverseEventsModule/otherEvents/9/stats/3
Triage: Medium
Other Adverse Event Addition Operation 230
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/10/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 231
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
49
After
0
replace /resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 232
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
15
After
0
replace /resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 233
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/10/stats/1
Triage: Medium
Other Adverse Event Addition Operation 234
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/10/stats/2
Triage: Medium
Other Adverse Event Addition Operation 235
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 49,
  "numAffected": 15
}
add /resultsSection/adverseEventsModule/otherEvents/10/stats/3
Triage: Medium
Other Adverse Event Addition Operation 236
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/11/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 237
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
13
After
0
replace /resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 238
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
6
After
0
replace /resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 239
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/11/stats/1
Triage: Medium
Other Adverse Event Addition Operation 240
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/11/stats/2
Triage: Medium
Other Adverse Event Addition Operation 241
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 13,
  "numAffected": 6
}
add /resultsSection/adverseEventsModule/otherEvents/11/stats/3
Triage: Medium
Other Adverse Event Addition Operation 242
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/12/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 243
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
48
After
0
replace /resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 244
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
18
After
0
replace /resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 245
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/12/stats/1
Triage: Medium
Other Adverse Event Addition Operation 246
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/otherEvents/12/stats/2
Triage: Medium
Other Adverse Event Addition Operation 247
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 48,
  "numAffected": 18
}
add /resultsSection/adverseEventsModule/otherEvents/12/stats/3
Triage: Medium
Other Adverse Event Addition Operation 248
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 2,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/13/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 249
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
26
After
0
replace /resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 250
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 251
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/13/stats/1
Triage: Medium
Other Adverse Event Addition Operation 252
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/13/stats/2
Triage: Medium
Other Adverse Event Addition Operation 253
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 26,
  "numAffected": 9
}
add /resultsSection/adverseEventsModule/otherEvents/13/stats/3
Triage: Medium
Other Adverse Event Addition Operation 254
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/14/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 255
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
13
After
0
replace /resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 256
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 257
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/14/stats/1
Triage: Medium
Other Adverse Event Addition Operation 258
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/14/stats/2
Triage: Medium
Other Adverse Event Addition Operation 259
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 13,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/14/stats/3
Triage: Medium
Other Adverse Event Addition Operation 260
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/15/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 261
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 262
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 263
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/15/stats/1
Triage: Medium
Other Adverse Event Addition Operation 264
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/15/stats/2
Triage: Medium
Other Adverse Event Addition Operation 265
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 5,
  "numAffected": 5
}
add /resultsSection/adverseEventsModule/otherEvents/15/stats/3
Triage: Medium
Other Adverse Event Addition Operation 266
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/16/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 267
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
13
After
0
replace /resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 268
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 269
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/16/stats/1
Triage: Medium
Other Adverse Event Addition Operation 270
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/16/stats/2
Triage: Medium
Other Adverse Event Addition Operation 271
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 13,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/16/stats/3
Triage: Medium
Other Adverse Event Addition Operation 272
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/17/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 273
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
24
After
0
replace /resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 274
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 275
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/17/stats/1
Triage: Medium
Other Adverse Event Addition Operation 276
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/otherEvents/17/stats/2
Triage: Medium
Other Adverse Event Addition Operation 277
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 24,
  "numAffected": 9
}
add /resultsSection/adverseEventsModule/otherEvents/17/stats/3
Triage: Medium
Other Adverse Event Addition Operation 278
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/18/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 279
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
13
After
0
replace /resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 280
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
12
After
0
replace /resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 281
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/18/stats/1
Triage: Medium
Other Adverse Event Addition Operation 282
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/18/stats/2
Triage: Medium
Other Adverse Event Addition Operation 283
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 13,
  "numAffected": 12
}
add /resultsSection/adverseEventsModule/otherEvents/18/stats/3
Triage: Medium
Other Adverse Event Addition Operation 284
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/19/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 285
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 286
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 287
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/19/stats/1
Triage: Medium
Other Adverse Event Addition Operation 288
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/19/stats/2
Triage: Medium
Other Adverse Event Addition Operation 289
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 9,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/19/stats/3
Triage: Medium
Other Adverse Event Addition Operation 290
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/20/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 291
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 292
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 293
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/20/stats/1
Triage: Medium
Other Adverse Event Addition Operation 294
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/20/stats/2
Triage: Medium
Other Adverse Event Addition Operation 295
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 5,
  "numAffected": 5
}
add /resultsSection/adverseEventsModule/otherEvents/20/stats/3
Triage: Medium
Other Adverse Event Addition Operation 296
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/21/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 297
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
49
After
2
replace /resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 298
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
10
After
1
replace /resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 299
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/21/stats/1
Triage: Medium
Other Adverse Event Addition Operation 300
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/21/stats/2
Triage: Medium
Other Adverse Event Addition Operation 301
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 49,
  "numAffected": 10
}
add /resultsSection/adverseEventsModule/otherEvents/21/stats/3
Triage: Medium
Other Adverse Event Addition Operation 302
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/22/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 303
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
19
After
0
replace /resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 304
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
7
After
0
replace /resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 305
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/22/stats/1
Triage: Medium
Other Adverse Event Addition Operation 306
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 4,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/otherEvents/22/stats/2
Triage: Medium
Other Adverse Event Addition Operation 307
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 19,
  "numAffected": 7
}
add /resultsSection/adverseEventsModule/otherEvents/22/stats/3
Triage: Medium
Other Adverse Event Addition Operation 308
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/23/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 309
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
203
After
5
replace /resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 310
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
47
After
2
replace /resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 311
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/23/stats/1
Triage: Medium
Other Adverse Event Addition Operation 312
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 11,
  "numAffected": 2
}
add /resultsSection/adverseEventsModule/otherEvents/23/stats/2
Triage: Medium
Other Adverse Event Addition Operation 313
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 203,
  "numAffected": 47
}
add /resultsSection/adverseEventsModule/otherEvents/23/stats/3
Triage: Medium
Other Adverse Event Addition Operation 314
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 10,
  "numAffected": 4
}
replace /resultsSection/adverseEventsModule/otherEvents/24/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 315
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 316
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 317
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/24/stats/1
Triage: Medium
Other Adverse Event Addition Operation 318
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/24/stats/2
Triage: Medium
Other Adverse Event Addition Operation 319
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 4,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/24/stats/3
Triage: Medium
Other Adverse Event Addition Operation 320
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 1,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/25/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 321
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
16
After
0
replace /resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 322
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 323
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/25/stats/1
Triage: Medium
Other Adverse Event Addition Operation 324
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/25/stats/2
Triage: Medium
Other Adverse Event Addition Operation 325
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 16,
  "numAffected": 9
}
add /resultsSection/adverseEventsModule/otherEvents/25/stats/3
Triage: Medium
Other Adverse Event Addition Operation 326
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/26/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 327
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
15
After
1
replace /resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 328
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
8
After
1
replace /resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 329
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/26/stats/1
Triage: Medium
Other Adverse Event Addition Operation 330
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/26/stats/2
Triage: Medium
Other Adverse Event Addition Operation 331
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 15,
  "numAffected": 8
}
add /resultsSection/adverseEventsModule/otherEvents/26/stats/3
Triage: Medium
Other Adverse Event Addition Operation 332
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/27/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 333
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
7
After
0
replace /resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 334
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
4
After
0
replace /resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 335
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/27/stats/1
Triage: Medium
Other Adverse Event Addition Operation 336
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/27/stats/2
Triage: Medium
Other Adverse Event Addition Operation 337
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 7,
  "numAffected": 4
}
add /resultsSection/adverseEventsModule/otherEvents/27/stats/3
Triage: Medium
Other Adverse Event Addition Operation 338
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/28/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 339
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 340
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 341
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/28/stats/1
Triage: Medium
Other Adverse Event Addition Operation 342
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/28/stats/2
Triage: Medium
Other Adverse Event Addition Operation 343
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 9,
  "numAffected": 5
}
add /resultsSection/adverseEventsModule/otherEvents/28/stats/3
Triage: Medium
Other Adverse Event Addition Operation 344
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/29/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 345
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
83
After
0
replace /resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 346
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
34
After
0
replace /resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 347
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/29/stats/1
Triage: Medium
Other Adverse Event Addition Operation 348
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 9,
  "numAffected": 3
}
add /resultsSection/adverseEventsModule/otherEvents/29/stats/2
Triage: Medium
Other Adverse Event Addition Operation 349
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 83,
  "numAffected": 34
}
add /resultsSection/adverseEventsModule/otherEvents/29/stats/3
Triage: Medium
Other Adverse Event Addition Operation 350
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 7,
  "numAffected": 3
}
replace /resultsSection/adverseEventsModule/otherEvents/30/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 351
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
11
After
0
replace /resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 352
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
9
After
0
replace /resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 353
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/30/stats/1
Triage: Medium
Other Adverse Event Addition Operation 354
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 1,
  "numAffected": 1
}
add /resultsSection/adverseEventsModule/otherEvents/30/stats/2
Triage: Medium
Other Adverse Event Addition Operation 355
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 11,
  "numAffected": 9
}
add /resultsSection/adverseEventsModule/otherEvents/30/stats/3
Triage: Medium
Other Adverse Event Addition Operation 356
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 3,
  "numAffected": 2
}
replace /resultsSection/adverseEventsModule/otherEvents/31/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 357
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
41
After
0
replace /resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 358
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
8
After
0
replace /resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 359
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/31/stats/1
Triage: Medium
Other Adverse Event Addition Operation 360
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/31/stats/2
Triage: Medium
Other Adverse Event Addition Operation 361
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 41,
  "numAffected": 8
}
add /resultsSection/adverseEventsModule/otherEvents/31/stats/3
Triage: Medium
Other Adverse Event Addition Operation 362
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/32/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 363
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
82
After
6
replace /resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 364
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
25
After
2
replace /resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 365
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/32/stats/1
Triage: Medium
Other Adverse Event Addition Operation 366
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 9,
  "numAffected": 2
}
add /resultsSection/adverseEventsModule/otherEvents/32/stats/2
Triage: Medium
Other Adverse Event Addition Operation 367
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 82,
  "numAffected": 25
}
add /resultsSection/adverseEventsModule/otherEvents/32/stats/3
Triage: Medium
Other Adverse Event Addition Operation 368
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 5,
  "numAffected": 4
}
replace /resultsSection/adverseEventsModule/otherEvents/33/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 369
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
58
After
0
replace /resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 370
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
11
After
0
replace /resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 371
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/33/stats/1
Triage: Medium
Other Adverse Event Addition Operation 372
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/33/stats/2
Triage: Medium
Other Adverse Event Addition Operation 373
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 58,
  "numAffected": 11
}
add /resultsSection/adverseEventsModule/otherEvents/33/stats/3
Triage: Medium
Other Adverse Event Addition Operation 374
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/34/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 375
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
87
After
0
replace /resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 376
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
36
After
0
replace /resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 377
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/34/stats/1
Triage: Medium
Other Adverse Event Addition Operation 378
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 8,
  "numAffected": 3
}
add /resultsSection/adverseEventsModule/otherEvents/34/stats/2
Triage: Medium
Other Adverse Event Addition Operation 379
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 87,
  "numAffected": 36
}
add /resultsSection/adverseEventsModule/otherEvents/34/stats/3
Triage: Medium
Other Adverse Event Addition Operation 380
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 8,
  "numAffected": 5
}
replace /resultsSection/adverseEventsModule/otherEvents/35/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 381
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
17
After
0
replace /resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 382
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
7
After
0
replace /resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 383
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/35/stats/1
Triage: Medium
Other Adverse Event Addition Operation 384
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/35/stats/2
Triage: Medium
Other Adverse Event Addition Operation 385
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 17,
  "numAffected": 7
}
add /resultsSection/adverseEventsModule/otherEvents/35/stats/3
Triage: Medium
Other Adverse Event Addition Operation 386
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
replace /resultsSection/adverseEventsModule/otherEvents/36/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 387
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
49
After
0
replace /resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 388
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
19
After
0
replace /resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 389
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/36/stats/1
Triage: Medium
Other Adverse Event Addition Operation 390
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 4,
  "numAffected": 2
}
add /resultsSection/adverseEventsModule/otherEvents/36/stats/2
Triage: Medium
Other Adverse Event Addition Operation 391
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 49,
  "numAffected": 19
}
add /resultsSection/adverseEventsModule/otherEvents/36/stats/3
Triage: Medium
Other Adverse Event Addition Operation 392
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 9,
  "numAffected": 5
}
replace /resultsSection/adverseEventsModule/otherEvents/37/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 393
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 394
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
5
After
0
replace /resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 395
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/37/stats/1
Triage: Medium
Other Adverse Event Addition Operation 396
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/37/stats/2
Triage: Medium
Other Adverse Event Addition Operation 397
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 5,
  "numAffected": 5
}
add /resultsSection/adverseEventsModule/otherEvents/37/stats/3
Triage: Medium
Other Adverse Event Addition Operation 398
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 2,
  "numAffected": 1
}
replace /resultsSection/adverseEventsModule/otherEvents/38/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 399
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
26
After
0
replace /resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 400
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
15
After
0
replace /resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 401
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/38/stats/1
Triage: Medium
Other Adverse Event Addition Operation 402
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/38/stats/2
Triage: Medium
Other Adverse Event Addition Operation 403
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 26,
  "numAffected": 15
}
add /resultsSection/adverseEventsModule/otherEvents/38/stats/3
Triage: Medium
Other Adverse Event Addition Operation 404
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 2,
  "numAffected": 2
}
replace /resultsSection/adverseEventsModule/otherEvents/39/stats/0/numEvents
Triage: Medium
Other Adverse Event Modification Operation 405
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
11
After
0
replace /resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAffected
Triage: Medium
Other Adverse Event Modification Operation 406
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
6
After
0
replace /resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAtRisk
Triage: Medium
Other Adverse Event Modification Operation 407
Matched rules
  • other_adverse_event_modification Modification of other adverse event result data is medium review priority.
Before
66
After
3
add /resultsSection/adverseEventsModule/otherEvents/39/stats/1
Triage: Medium
Other Adverse Event Addition Operation 408
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG001",
  "numAtRisk": 3,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/39/stats/2
Triage: Medium
Other Adverse Event Addition Operation 409
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG002",
  "numAtRisk": 66,
  "numEvents": 11,
  "numAffected": 6
}
add /resultsSection/adverseEventsModule/otherEvents/39/stats/3
Triage: Medium
Other Adverse Event Addition Operation 410
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "groupId": "EG003",
  "numAtRisk": 6,
  "numEvents": 0,
  "numAffected": 0
}
add /resultsSection/adverseEventsModule/otherEvents/40
Triage: Medium
Other Adverse Event Addition Operation 411
Matched rules
  • other_adverse_event_addition Addition of other adverse event result data is medium review priority.
After
{
  "term": "PAIN",
  "stats": [
    {
      "groupId": "EG000",
      "numAtRisk": 3,
      "numEvents": 3,
      "numAffected": 2
    },
    {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 14,
      "numAffected": 2
    },
    {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 0,
      "numAffected": 0
    },
    {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 15,
      "numAffected": 4
    }
  ],
  "organSystem": "General disorders",
  "assessmentType": "SYSTEMATIC_ASSESSMENT",
  "sourceVocabulary": "CTCAE v 4.0"
}
add /resultsSection/adverseEventsModule/timeFrame
Triage: Uncategorized
Uncategorized Operation 412
After
every 3 weeks up to 43 months
Design Trial model, phase, allocation, masking, arms, or interventions. Triage: High 1 ops
replace /protocolSection/armsInterventionsModule/interventions/0/description
Triage: High
Arm Intervention Change Operation 6
Matched rules
  • arms_or_interventions_change Arms or interventions changes can alter treatment/comparator structure.
Before
<p>Phase I: dose escalating portion with the starting dose of amrubicin at 90mg&#x2F;m2 IV q21 days.
Dose escalations are as follows:</p><p>DL2 - 100mg&#x2F;m2; DL3 - 110mg&#x2F;m2; and DL4 - 120mg&#x2F;m2.
All cycles are q21 days</p><p>Phase II: Amrubicin will be administered at the maximum tolerated dose established in Phase I by IV every 21 days</p>
After
<p>Phase I: dose-escalating portion with the starting dose of amrubicin at 90mg&#x2F;m^2 IV q21 days.
Dose escalations are as follows:</p><p>DL2 - 100mg&#x2F;m^2; DL3 - 110mg&#x2F;m^2; and DL4 - 120mg&#x2F;m^2.
All cycles are q21 days</p><p>Phase II: Amrubicin will be administered at the maximum tolerated dose established in Phase I by IV every 21 days</p>
Secondary outcomes Additional endpoints and outcome descriptions. Triage: High 7 ops
replace /protocolSection/outcomesModule/secondaryOutcomes/0/description
Triage: High
Secondary Outcome Change Operation 9
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)
After
Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs).
replace /protocolSection/outcomesModule/secondaryOutcomes/0/timeFrame
Triage: High
Secondary Outcome Change Operation 10
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
every 6 weeks until treatment discontinuation, expected average 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
replace /protocolSection/outcomesModule/secondaryOutcomes/1/measure
Triage: High
Secondary Outcome Change Operation 11
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
Overall Survival (OS)
After
Overall Survival (OS) of MTD&#x2F;Phase II Patients
replace /protocolSection/outcomesModule/secondaryOutcomes/1/description
Triage: High
Secondary Outcome Change Operation 12
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
Measured from Day 1 of study drug administration to date of death due to any cause.
After
Measured from Day 1 of study drug administration to date of death due to any cause.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure.
replace /protocolSection/outcomesModule/secondaryOutcomes/1/timeFrame
Triage: High
Secondary Outcome Change Operation 13
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
every 6 weeks until treatment discontinuation, expected average of 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
replace /protocolSection/outcomesModule/secondaryOutcomes/2/description
Triage: High
Secondary Outcome Change Operation 14
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
The number of patients with observed complete response [CR] or partial response [PR].
Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR
After
The number of patients with observed complete response [CR] or partial response [PR].
Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
replace /protocolSection/outcomesModule/secondaryOutcomes/2/timeFrame
Triage: High
Secondary Outcome Change Operation 15
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
every 6 weeks until treatment discontinuation, expected average 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
Other registry fields Changes outside the current high-signal rule families. Triage: Uncategorized 64 ops
replace /protocolSection/statusModule/statusVerifiedDate
Triage: Uncategorized
Uncategorized Operation 1
Before
2014-12
After
2022-04
replace /protocolSection/statusModule/lastUpdateSubmitDate
Triage: Uncategorized
Uncategorized Operation 2
Before
2014-12-22
After
2022-04-05
replace /protocolSection/statusModule/lastUpdatePostDateStruct/date
Triage: Uncategorized
Uncategorized Operation 3
Before
2015-01-06
After
2022-05-03
replace /protocolSection/statusModule/lastUpdatePostDateStruct/type
Triage: Uncategorized
Uncategorized Operation 4
Before
ESTIMATED
After
ACTUAL
add /resultsSection/participantFlowModule/groups/4
Triage: Uncategorized
Uncategorized Operation 16
After
{
  "id": "FG004",
  "title": "Phase II",
  "description": "Amrubicin - 110 mg&#x2F;m^2 IV every 21 days"
}
replace /resultsSection/participantFlowModule/periods/0/title
Triage: Uncategorized
Uncategorized Operation 17
Before
Phase I
After
Overall Study
add /resultsSection/participantFlowModule/periods/0/milestones/0/achievements/4
Triage: Uncategorized
Uncategorized Operation 18
After
{
  "groupId": "FG004",
  "numSubjects": "63"
}
add /resultsSection/participantFlowModule/periods/0/milestones/1/achievements/4
Triage: Uncategorized
Uncategorized Operation 19
After
{
  "groupId": "FG004",
  "numSubjects": "0"
}
add /resultsSection/participantFlowModule/periods/0/milestones/2/achievements/4
Triage: Uncategorized
Uncategorized Operation 20
After
{
  "groupId": "FG004",
  "numSubjects": "63"
}
remove /resultsSection/participantFlowModule/periods/1
Triage: Uncategorized
Uncategorized Operation 21
Before
{
  "title": "Phase II",
  "milestones": [
    {
      "type": "STARTED",
      "achievements": [
        {
          "groupId": "FG000",
          "numSubjects": "0"
        },
        {
          "groupId": "FG001",
          "numSubjects": "0"
        },
        {
          "comment": "Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled",
          "groupId": "FG002",
          "numSubjects": "66"
        },
        {
          "groupId": "FG003",
          "numSubjects": "0"
        }
      ]
    },
    {
      "type": "COMPLETED",
      "achievements": [
        {
          "groupId": "FG000",
          "numSubjects": "0"
        },
        {
          "groupId": "FG001",
          "numSubjects": "0"
        },
        {
          "comment": "Patients continued recieving treatment until disease progression or unacceptable toxicity",
          "groupId": "FG002",
          "numSubjects": "0"
        },
        {
          "groupId": "FG003",
          "numSubjects": "0"
        }
      ]
    },
    {
      "type": "NOT COMPLETED",
      "achievements": [
        {
          "groupId": "FG000",
          "numSubjects": "0"
        },
        {
          "groupId": "FG001",
          "numSubjects": "0"
        },
        {
          "groupId": "FG002",
          "numSubjects": "66"
        },
        {
          "groupId": "FG003",
          "numSubjects": "0"
        }
      ]
    }
  ]
}
remove /resultsSection/baselineCharacteristicsModule/populationDescription
Triage: Uncategorized
Uncategorized Operation 22
Before
Includes Phase I and Phase II patients
replace /resultsSection/baselineCharacteristicsModule/groups/0/title
Triage: Uncategorized
Uncategorized Operation 23
Before
All Patients
After
Phase I - Dose Level 1
replace /resultsSection/baselineCharacteristicsModule/groups/0/description
Triage: Uncategorized
Uncategorized Operation 24
Before
Includes all Phase I and Phase II patients treated at all dose levels (total enrollment = 78 patients)
After
Amrubicin -90 mg&#x2F;m^2 by intravenous(IV) every 21days
add /resultsSection/baselineCharacteristicsModule/groups/1
Triage: Uncategorized
Uncategorized Operation 25
After
{
  "id": "BG001",
  "title": "Phase I - Dose Level 2",
  "description": "Amrubicin -100 mg&#x2F;m^2 IV every 21days"
}
add /resultsSection/baselineCharacteristicsModule/groups/2
Triage: Uncategorized
Uncategorized Operation 26
After
{
  "id": "BG002",
  "title": "Phase I - Dose Level 3",
  "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
}
add /resultsSection/baselineCharacteristicsModule/groups/3
Triage: Uncategorized
Uncategorized Operation 27
After
{
  "id": "BG003",
  "title": "Phase I - Dose Level 4",
  "description": "Amrubicin -120 mg&#x2F;m^2 every 21 days"
}
add /resultsSection/baselineCharacteristicsModule/groups/4
Triage: Uncategorized
Uncategorized Operation 28
After
{
  "id": "BG004",
  "title": "Phase II - Dose Level 3",
  "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
}
add /resultsSection/baselineCharacteristicsModule/groups/5
Triage: Uncategorized
Uncategorized Operation 29
After
{
  "id": "BG005",
  "title": "Total",
  "description": "Total of all reporting groups"
}
replace /resultsSection/baselineCharacteristicsModule/denoms/0/counts/0/value
Triage: Uncategorized
Uncategorized Operation 30
Before
78
After
3
add /resultsSection/baselineCharacteristicsModule/denoms/0/counts/1
Triage: Uncategorized
Uncategorized Operation 31
After
{
  "value": "3",
  "groupId": "BG001"
}
add /resultsSection/baselineCharacteristicsModule/denoms/0/counts/2
Triage: Uncategorized
Uncategorized Operation 32
After
{
  "value": "3",
  "groupId": "BG002"
}
add /resultsSection/baselineCharacteristicsModule/denoms/0/counts/3
Triage: Uncategorized
Uncategorized Operation 33
After
{
  "value": "6",
  "groupId": "BG003"
}
add /resultsSection/baselineCharacteristicsModule/denoms/0/counts/4
Triage: Uncategorized
Uncategorized Operation 34
After
{
  "value": "63",
  "groupId": "BG004"
}
add /resultsSection/baselineCharacteristicsModule/denoms/0/counts/5
Triage: Uncategorized
Uncategorized Operation 35
After
{
  "value": "78",
  "groupId": "BG005"
}
replace /resultsSection/baselineCharacteristicsModule/measures/0/title
Triage: Uncategorized
Uncategorized Operation 36
Before
Age, Continuous
After
Age, Categorical
replace /resultsSection/baselineCharacteristicsModule/measures/0/paramType
Triage: Uncategorized
Uncategorized Operation 37
Before
MEDIAN
After
COUNT_OF_PARTICIPANTS
remove /resultsSection/baselineCharacteristicsModule/measures/0/dispersionType
Triage: Uncategorized
Uncategorized Operation 38
Before
FULL_RANGE
replace /resultsSection/baselineCharacteristicsModule/measures/0/unitOfMeasure
Triage: Uncategorized
Uncategorized Operation 39
Before
Years
After
Participants
replace /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/value
Triage: Uncategorized
Uncategorized Operation 40
Before
58
After
0
remove /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/lowerLimit
Triage: Uncategorized
Uncategorized Operation 41
Before
27
remove /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/upperLimit
Triage: Uncategorized
Uncategorized Operation 42
Before
86
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1
Triage: Uncategorized
Uncategorized Operation 43
After
{
  "value": "0",
  "groupId": "BG001"
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/2
Triage: Uncategorized
Uncategorized Operation 44
After
{
  "value": "0",
  "groupId": "BG002"
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/3
Triage: Uncategorized
Uncategorized Operation 45
After
{
  "value": "0",
  "groupId": "BG003"
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/4
Triage: Uncategorized
Uncategorized Operation 46
After
{
  "value": "0",
  "groupId": "BG004"
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/5
Triage: Uncategorized
Uncategorized Operation 47
After
{
  "value": "0",
  "groupId": "BG005"
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/title
Triage: Uncategorized
Uncategorized Operation 48
After
&lt;=18 years
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/1
Triage: Uncategorized
Uncategorized Operation 49
After
{
  "title": "Between 18 and 65 years",
  "measurements": [
    {
      "value": "3",
      "groupId": "BG000"
    },
    {
      "value": "2",
      "groupId": "BG001"
    },
    {
      "value": "3",
      "groupId": "BG002"
    },
    {
      "value": "6",
      "groupId": "BG003"
    },
    {
      "value": "44",
      "groupId": "BG004"
    },
    {
      "value": "58",
      "groupId": "BG005"
    }
  ]
}
add /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/2
Triage: Uncategorized
Uncategorized Operation 50
After
{
  "title": "&gt;=65 years",
  "measurements": [
    {
      "value": "0",
      "groupId": "BG000"
    },
    {
      "value": "1",
      "groupId": "BG001"
    },
    {
      "value": "0",
      "groupId": "BG002"
    },
    {
      "value": "0",
      "groupId": "BG003"
    },
    {
      "value": "19",
      "groupId": "BG004"
    },
    {
      "value": "20",
      "groupId": "BG005"
    }
  ]
}
replace /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/0/value
Triage: Uncategorized
Uncategorized Operation 51
Before
78
After
3
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1
Triage: Uncategorized
Uncategorized Operation 52
After
{
  "value": "3",
  "groupId": "BG001"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/2
Triage: Uncategorized
Uncategorized Operation 53
After
{
  "value": "3",
  "groupId": "BG002"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/3
Triage: Uncategorized
Uncategorized Operation 54
After
{
  "value": "6",
  "groupId": "BG003"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/4
Triage: Uncategorized
Uncategorized Operation 55
After
{
  "value": "63",
  "groupId": "BG004"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/5
Triage: Uncategorized
Uncategorized Operation 56
After
{
  "value": "78",
  "groupId": "BG005"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/1
Triage: Uncategorized
Uncategorized Operation 57
After
{
  "value": "0",
  "groupId": "BG001"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/2
Triage: Uncategorized
Uncategorized Operation 58
After
{
  "value": "0",
  "groupId": "BG002"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/3
Triage: Uncategorized
Uncategorized Operation 59
After
{
  "value": "0",
  "groupId": "BG003"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/4
Triage: Uncategorized
Uncategorized Operation 60
After
{
  "value": "0",
  "groupId": "BG004"
}
add /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/5
Triage: Uncategorized
Uncategorized Operation 61
After
{
  "value": "0",
  "groupId": "BG005"
}
replace /resultsSection/baselineCharacteristicsModule/measures/2/title
Triage: Uncategorized
Uncategorized Operation 62
Before
Region of Enrollment
After
Ethnicity (NIH&#x2F;OMB)
replace /resultsSection/baselineCharacteristicsModule/measures/2/paramType
Triage: Uncategorized
Uncategorized Operation 63
Before
NUMBER
After
COUNT_OF_PARTICIPANTS
replace /resultsSection/baselineCharacteristicsModule/measures/2/unitOfMeasure
Triage: Uncategorized
Uncategorized Operation 64
Before
participants
After
Participants
remove /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/title
Triage: Uncategorized
Uncategorized Operation 65
Before
United States
replace /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/0/value
Triage: Uncategorized
Uncategorized Operation 66
Before
78
After
0
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1
Triage: Uncategorized
Uncategorized Operation 67
After
{
  "value": "0",
  "groupId": "BG001"
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/2
Triage: Uncategorized
Uncategorized Operation 68
After
{
  "value": "0",
  "groupId": "BG002"
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/3
Triage: Uncategorized
Uncategorized Operation 69
After
{
  "value": "1",
  "groupId": "BG003"
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/4
Triage: Uncategorized
Uncategorized Operation 70
After
{
  "value": "3",
  "groupId": "BG004"
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/5
Triage: Uncategorized
Uncategorized Operation 71
After
{
  "value": "4",
  "groupId": "BG005"
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/title
Triage: Uncategorized
Uncategorized Operation 72
After
Hispanic or Latino
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1
Triage: Uncategorized
Uncategorized Operation 73
After
{
  "title": "Not Hispanic or Latino",
  "measurements": [
    {
      "value": "1",
      "groupId": "BG000"
    },
    {
      "value": "1",
      "groupId": "BG001"
    },
    {
      "value": "3",
      "groupId": "BG002"
    },
    {
      "value": "5",
      "groupId": "BG003"
    },
    {
      "value": "53",
      "groupId": "BG004"
    },
    {
      "value": "63",
      "groupId": "BG005"
    }
  ]
}
add /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2
Triage: Uncategorized
Uncategorized Operation 74
After
{
  "title": "Unknown or Not Reported",
  "measurements": [
    {
      "value": "2",
      "groupId": "BG000"
    },
    {
      "value": "2",
      "groupId": "BG001"
    },
    {
      "value": "0",
      "groupId": "BG002"
    },
    {
      "value": "0",
      "groupId": "BG003"
    },
    {
      "value": "7",
      "groupId": "BG004"
    },
    {
      "value": "11",
      "groupId": "BG005"
    }
  ]
}
add /resultsSection/baselineCharacteristicsModule/measures/3
Triage: Uncategorized
Uncategorized Operation 75
After
{
  "title": "Race (NIH&#x2F;OMB)",
  "classes": [
    {
      "categories": [
        {
          "title": "American Indian or Alaska Native",
          "measurements": [
            {
              "value": "0",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "0",
              "groupId": "BG004"
            },
            {
              "value": "0",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "Asian",
          "measurements": [
            {
              "value": "0",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "0",
              "groupId": "BG004"
            },
            {
              "value": "0",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "Native Hawaiian or Other Pacific Islander",
          "measurements": [
            {
              "value": "0",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "0",
              "groupId": "BG004"
            },
            {
              "value": "0",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "Black or African American",
          "measurements": [
            {
              "value": "1",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "7",
              "groupId": "BG004"
            },
            {
              "value": "8",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "White",
          "measurements": [
            {
              "value": "2",
              "groupId": "BG000"
            },
            {
              "value": "3",
              "groupId": "BG001"
            },
            {
              "value": "3",
              "groupId": "BG002"
            },
            {
              "value": "6",
              "groupId": "BG003"
            },
            {
              "value": "53",
              "groupId": "BG004"
            },
            {
              "value": "67",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "More than one race",
          "measurements": [
            {
              "value": "0",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "0",
              "groupId": "BG004"
            },
            {
              "value": "0",
              "groupId": "BG005"
            }
          ]
        },
        {
          "title": "Unknown or Not Reported",
          "measurements": [
            {
              "value": "0",
              "groupId": "BG000"
            },
            {
              "value": "0",
              "groupId": "BG001"
            },
            {
              "value": "0",
              "groupId": "BG002"
            },
            {
              "value": "0",
              "groupId": "BG003"
            },
            {
              "value": "3",
              "groupId": "BG004"
            },
            {
              "value": "3",
              "groupId": "BG005"
            }
          ]
        }
      ]
    }
  ],
  "paramType": "COUNT_OF_PARTICIPANTS",
  "unitOfMeasure": "Participants"
}
Results outcome measures Posted result outcome measures and result-level endpoint data. Triage: Uncategorized 42 ops
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/0/title
Triage: Uncategorized
Uncategorized Operation 76
Before
Progression-free Survival (PFS)
After
Progression-Free Survival (PFS) of MTD&#x2F;Phase II Patients
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/0/description
Triage: Uncategorized
Uncategorized Operation 77
Before
Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on study.
Progression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions
After
Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.
Progression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/0/populationDescription
Triage: Uncategorized
Uncategorized Operation 78
Before
Includes patients treated at the MTD (Dose Level 3)
After
Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.
The 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.
The phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
The other 12 phase I pts who were not treated at the MTD are excluded.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/description
Triage: Uncategorized
Uncategorized Operation 79
Before
Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)
After
Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs).
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/populationDescription
Triage: Uncategorized
Uncategorized Operation 80
Before
Includes patients treated at the MTD (Dose Level 3)
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/paramType
Triage: Uncategorized
Uncategorized Operation 81
Before
NUMBER
After
COUNT_OF_PARTICIPANTS
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/unitOfMeasure
Triage: Uncategorized
Uncategorized Operation 82
Before
participants
After
Participants
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/timeFrame
Triage: Uncategorized
Uncategorized Operation 83
Before
every 6 weeks until treatment discontinuation, expected average 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/title
Triage: Uncategorized
Uncategorized Operation 84
Before
Amrubicin
After
Dose Level 1
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/description
Triage: Uncategorized
Uncategorized Operation 85
Before
Systemic therapy with amrubicin
After
Amrubicin -90 mg&#x2F;m^2 by intravenous(IV) every 21days
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/1
Triage: Uncategorized
Uncategorized Operation 86
After
{
  "id": "OG001",
  "title": "Dose Level 2",
  "description": "Amrubicin -100 mg&#x2F;m^2 IV every 21days"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/2
Triage: Uncategorized
Uncategorized Operation 87
After
{
  "id": "OG002",
  "title": "Dose Level 3",
  "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/3
Triage: Uncategorized
Uncategorized Operation 88
After
{
  "id": "OG003",
  "title": "Dose Level 4",
  "description": "Amrubicin -120 mg&#x2F;m^2 IV every 21 days"
}
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/0/value
Triage: Uncategorized
Uncategorized Operation 89
Before
66
After
3
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/1
Triage: Uncategorized
Uncategorized Operation 90
After
{
  "value": "3",
  "groupId": "OG001"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/2
Triage: Uncategorized
Uncategorized Operation 91
After
{
  "value": "66",
  "groupId": "OG002"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/3
Triage: Uncategorized
Uncategorized Operation 92
After
{
  "value": "6",
  "groupId": "OG003"
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/title
Triage: Uncategorized
Uncategorized Operation 93
Before
Neutropenia
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/0/value
Triage: Uncategorized
Uncategorized Operation 94
Before
19
After
3
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/1
Triage: Uncategorized
Uncategorized Operation 95
After
{
  "value": "3",
  "groupId": "OG001"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/2
Triage: Uncategorized
Uncategorized Operation 96
After
{
  "value": "65",
  "groupId": "OG002"
}
add /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/3
Triage: Uncategorized
Uncategorized Operation 97
After
{
  "value": "6",
  "groupId": "OG003"
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 98
Before
{
  "title": "Febrile neutropenia",
  "categories": [
    {
      "measurements": [
        {
          "value": "4",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 99
Before
{
  "title": "Leukopenia",
  "categories": [
    {
      "measurements": [
        {
          "value": "26",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 100
Before
{
  "title": "Anemia",
  "categories": [
    {
      "measurements": [
        {
          "value": "3",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 101
Before
{
  "title": "Thrombocytopenia",
  "categories": [
    {
      "measurements": [
        {
          "value": "4",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 102
Before
{
  "title": "Dehydration",
  "categories": [
    {
      "measurements": [
        {
          "value": "3",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 103
Before
{
  "title": "Anorexia",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 104
Before
{
  "title": "Bone pain",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 105
Before
{
  "title": "Diarrhea",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 106
Before
{
  "title": "Fatigue",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 107
Before
{
  "title": "Nausea&#x2F;vomiting",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 108
Before
{
  "title": "Pulmonary infiltrates",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 109
Before
{
  "title": "Typhlitis",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
remove /resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1
Triage: Uncategorized
Uncategorized Operation 110
Before
{
  "title": "Decreased ejection fraction",
  "categories": [
    {
      "measurements": [
        {
          "value": "1",
          "groupId": "OG000"
        }
      ]
    }
  ]
}
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/2/title
Triage: Uncategorized
Uncategorized Operation 111
Before
Overall Survival (OS)
After
Overall Survival (OS) of MTD&#x2F;Phase II Patients
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/2/description
Triage: Uncategorized
Uncategorized Operation 112
Before
Measured from Day 1 of study drug administration to date of death due to any cause.
After
Measured from Day 1 of study drug administration to date of death due to any cause.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/2/populationDescription
Triage: Uncategorized
Uncategorized Operation 113
Before
Includes patients treated at the MTD (Dose Level 3)
After
Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.
The 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.
The phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
The other 12 phase I pts who were not treated at the MTD are excluded.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/2/timeFrame
Triage: Uncategorized
Uncategorized Operation 114
Before
every 6 weeks until treatment discontinuation, expected average of 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/3/description
Triage: Uncategorized
Uncategorized Operation 115
Before
The number of patients with observed complete response [CR] or partial response [PR].
Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR
After
The number of patients with observed complete response [CR] or partial response [PR].
Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.
This outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.
The phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/3/populationDescription
Triage: Uncategorized
Uncategorized Operation 116
Before
Includes patients treated at the MTD (Dose Level 3)
After
Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.
The 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.
The phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.
The other 12 phase I pts who were not treated at the MTD are excluded.
replace /resultsSection/outcomeMeasuresModule/outcomeMeasures/3/timeFrame
Triage: Uncategorized
Uncategorized Operation 117
Before
every 6 weeks until treatment discontinuation, expected average 18 months
After
every 6 weeks until treatment discontinuation, up to 43 months
Sponsor and administrative fields Sponsor, collaborator, oversight, or registry maintenance changes. Triage: Uncategorized 1 ops
replace /protocolSection/sponsorCollaboratorsModule/collaborators/0/name
Triage: Uncategorized
Uncategorized Operation 5
Before
Celgene Corporation
After
Celgene
Raw JSON Patch
[
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/statusVerifiedDate",
    "value": "2022-04"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdateSubmitDate",
    "value": "2022-04-05"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
    "value": "2022-05-03"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdatePostDateStruct/type",
    "value": "ACTUAL"
  },
  {
    "op": "replace",
    "path": "/protocolSection/sponsorCollaboratorsModule/collaborators/0/name",
    "value": "Celgene"
  },
  {
    "op": "replace",
    "path": "/protocolSection/armsInterventionsModule/interventions/0/description",
    "value": "<p>Phase I: dose-escalating portion with the starting dose of amrubicin at 90mg&#x2F;m^2 IV q21 days.\nDose escalations are as follows:</p><p>DL2 - 100mg&#x2F;m^2; DL3 - 110mg&#x2F;m^2; and DL4 - 120mg&#x2F;m^2.\nAll cycles are q21 days</p><p>Phase II: Amrubicin will be administered at the maximum tolerated dose established in Phase I by IV every 21 days</p>"
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/primaryOutcomes/0/measure",
    "value": "Progression-Free Survival (PFS) of MTD&#x2F;Phase II Patients"
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/primaryOutcomes/0/description",
    "value": "Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.\nProgression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/0/description",
    "value": "Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/0/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
    "value": "Overall Survival (OS) of MTD&#x2F;Phase II Patients"
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/1/description",
    "value": "Measured from Day 1 of study drug administration to date of death due to any cause.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/1/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
    "value": "The number of patients with observed complete response [CR] or partial response [PR].\nPer Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/2/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "add",
    "path": "/resultsSection/participantFlowModule/groups/4",
    "value": {
      "id": "FG004",
      "title": "Phase II",
      "description": "Amrubicin - 110 mg&#x2F;m^2 IV every 21 days"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/participantFlowModule/periods/0/title",
    "value": "Overall Study"
  },
  {
    "op": "add",
    "path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/4",
    "value": {
      "groupId": "FG004",
      "numSubjects": "63"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/4",
    "value": {
      "groupId": "FG004",
      "numSubjects": "0"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/4",
    "value": {
      "groupId": "FG004",
      "numSubjects": "63"
    }
  },
  {
    "op": "remove",
    "path": "/resultsSection/participantFlowModule/periods/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/baselineCharacteristicsModule/populationDescription"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/0/title",
    "value": "Phase I - Dose Level 1"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/0/description",
    "value": "Amrubicin -90 mg&#x2F;m^2 by intravenous(IV) every 21days"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/1",
    "value": {
      "id": "BG001",
      "title": "Phase I - Dose Level 2",
      "description": "Amrubicin -100 mg&#x2F;m^2 IV every 21days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/2",
    "value": {
      "id": "BG002",
      "title": "Phase I - Dose Level 3",
      "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/3",
    "value": {
      "id": "BG003",
      "title": "Phase I - Dose Level 4",
      "description": "Amrubicin -120 mg&#x2F;m^2 every 21 days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/4",
    "value": {
      "id": "BG004",
      "title": "Phase II - Dose Level 3",
      "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/groups/5",
    "value": {
      "id": "BG005",
      "title": "Total",
      "description": "Total of all reporting groups"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/0/value",
    "value": "3"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/1",
    "value": {
      "value": "3",
      "groupId": "BG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/2",
    "value": {
      "value": "3",
      "groupId": "BG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/3",
    "value": {
      "value": "6",
      "groupId": "BG003"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/4",
    "value": {
      "value": "63",
      "groupId": "BG004"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/5",
    "value": {
      "value": "78",
      "groupId": "BG005"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/title",
    "value": "Age, Categorical"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/paramType",
    "value": "COUNT_OF_PARTICIPANTS"
  },
  {
    "op": "remove",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/dispersionType"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/unitOfMeasure",
    "value": "Participants"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/value",
    "value": "0"
  },
  {
    "op": "remove",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/lowerLimit"
  },
  {
    "op": "remove",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/upperLimit"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1",
    "value": {
      "value": "0",
      "groupId": "BG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/2",
    "value": {
      "value": "0",
      "groupId": "BG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/3",
    "value": {
      "value": "0",
      "groupId": "BG003"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/4",
    "value": {
      "value": "0",
      "groupId": "BG004"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/5",
    "value": {
      "value": "0",
      "groupId": "BG005"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/title",
    "value": "&lt;=18 years"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/1",
    "value": {
      "title": "Between 18 and 65 years",
      "measurements": [
        {
          "value": "3",
          "groupId": "BG000"
        },
        {
          "value": "2",
          "groupId": "BG001"
        },
        {
          "value": "3",
          "groupId": "BG002"
        },
        {
          "value": "6",
          "groupId": "BG003"
        },
        {
          "value": "44",
          "groupId": "BG004"
        },
        {
          "value": "58",
          "groupId": "BG005"
        }
      ]
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/2",
    "value": {
      "title": "&gt;=65 years",
      "measurements": [
        {
          "value": "0",
          "groupId": "BG000"
        },
        {
          "value": "1",
          "groupId": "BG001"
        },
        {
          "value": "0",
          "groupId": "BG002"
        },
        {
          "value": "0",
          "groupId": "BG003"
        },
        {
          "value": "19",
          "groupId": "BG004"
        },
        {
          "value": "20",
          "groupId": "BG005"
        }
      ]
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/0/value",
    "value": "3"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1",
    "value": {
      "value": "3",
      "groupId": "BG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/2",
    "value": {
      "value": "3",
      "groupId": "BG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/3",
    "value": {
      "value": "6",
      "groupId": "BG003"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/4",
    "value": {
      "value": "63",
      "groupId": "BG004"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/5",
    "value": {
      "value": "78",
      "groupId": "BG005"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/1",
    "value": {
      "value": "0",
      "groupId": "BG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/2",
    "value": {
      "value": "0",
      "groupId": "BG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/3",
    "value": {
      "value": "0",
      "groupId": "BG003"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/4",
    "value": {
      "value": "0",
      "groupId": "BG004"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/5",
    "value": {
      "value": "0",
      "groupId": "BG005"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/title",
    "value": "Ethnicity (NIH&#x2F;OMB)"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/paramType",
    "value": "COUNT_OF_PARTICIPANTS"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/unitOfMeasure",
    "value": "Participants"
  },
  {
    "op": "remove",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/title"
  },
  {
    "op": "replace",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/0/value",
    "value": "0"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1",
    "value": {
      "value": "0",
      "groupId": "BG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/2",
    "value": {
      "value": "0",
      "groupId": "BG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/3",
    "value": {
      "value": "1",
      "groupId": "BG003"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/4",
    "value": {
      "value": "3",
      "groupId": "BG004"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/5",
    "value": {
      "value": "4",
      "groupId": "BG005"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/title",
    "value": "Hispanic or Latino"
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1",
    "value": {
      "title": "Not Hispanic or Latino",
      "measurements": [
        {
          "value": "1",
          "groupId": "BG000"
        },
        {
          "value": "1",
          "groupId": "BG001"
        },
        {
          "value": "3",
          "groupId": "BG002"
        },
        {
          "value": "5",
          "groupId": "BG003"
        },
        {
          "value": "53",
          "groupId": "BG004"
        },
        {
          "value": "63",
          "groupId": "BG005"
        }
      ]
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2",
    "value": {
      "title": "Unknown or Not Reported",
      "measurements": [
        {
          "value": "2",
          "groupId": "BG000"
        },
        {
          "value": "2",
          "groupId": "BG001"
        },
        {
          "value": "0",
          "groupId": "BG002"
        },
        {
          "value": "0",
          "groupId": "BG003"
        },
        {
          "value": "7",
          "groupId": "BG004"
        },
        {
          "value": "11",
          "groupId": "BG005"
        }
      ]
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/baselineCharacteristicsModule/measures/3",
    "value": {
      "title": "Race (NIH&#x2F;OMB)",
      "classes": [
        {
          "categories": [
            {
              "title": "American Indian or Alaska Native",
              "measurements": [
                {
                  "value": "0",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "0",
                  "groupId": "BG004"
                },
                {
                  "value": "0",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "Asian",
              "measurements": [
                {
                  "value": "0",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "0",
                  "groupId": "BG004"
                },
                {
                  "value": "0",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "Native Hawaiian or Other Pacific Islander",
              "measurements": [
                {
                  "value": "0",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "0",
                  "groupId": "BG004"
                },
                {
                  "value": "0",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "Black or African American",
              "measurements": [
                {
                  "value": "1",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "7",
                  "groupId": "BG004"
                },
                {
                  "value": "8",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "White",
              "measurements": [
                {
                  "value": "2",
                  "groupId": "BG000"
                },
                {
                  "value": "3",
                  "groupId": "BG001"
                },
                {
                  "value": "3",
                  "groupId": "BG002"
                },
                {
                  "value": "6",
                  "groupId": "BG003"
                },
                {
                  "value": "53",
                  "groupId": "BG004"
                },
                {
                  "value": "67",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "More than one race",
              "measurements": [
                {
                  "value": "0",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "0",
                  "groupId": "BG004"
                },
                {
                  "value": "0",
                  "groupId": "BG005"
                }
              ]
            },
            {
              "title": "Unknown or Not Reported",
              "measurements": [
                {
                  "value": "0",
                  "groupId": "BG000"
                },
                {
                  "value": "0",
                  "groupId": "BG001"
                },
                {
                  "value": "0",
                  "groupId": "BG002"
                },
                {
                  "value": "0",
                  "groupId": "BG003"
                },
                {
                  "value": "3",
                  "groupId": "BG004"
                },
                {
                  "value": "3",
                  "groupId": "BG005"
                }
              ]
            }
          ]
        }
      ],
      "paramType": "COUNT_OF_PARTICIPANTS",
      "unitOfMeasure": "Participants"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/title",
    "value": "Progression-Free Survival (PFS) of MTD&#x2F;Phase II Patients"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/description",
    "value": "Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.\nProgression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/populationDescription",
    "value": "Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/description",
    "value": "Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)."
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/populationDescription"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/paramType",
    "value": "COUNT_OF_PARTICIPANTS"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/unitOfMeasure",
    "value": "Participants"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/title",
    "value": "Dose Level 1"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/description",
    "value": "Amrubicin -90 mg&#x2F;m^2 by intravenous(IV) every 21days"
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/1",
    "value": {
      "id": "OG001",
      "title": "Dose Level 2",
      "description": "Amrubicin -100 mg&#x2F;m^2 IV every 21days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/2",
    "value": {
      "id": "OG002",
      "title": "Dose Level 3",
      "description": "Amrubicin -110 mg&#x2F;m^2 IV every 21days"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/3",
    "value": {
      "id": "OG003",
      "title": "Dose Level 4",
      "description": "Amrubicin -120 mg&#x2F;m^2 IV every 21 days"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/0/value",
    "value": "3"
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/1",
    "value": {
      "value": "3",
      "groupId": "OG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/2",
    "value": {
      "value": "66",
      "groupId": "OG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/3",
    "value": {
      "value": "6",
      "groupId": "OG003"
    }
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/title"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/0/value",
    "value": "3"
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/1",
    "value": {
      "value": "3",
      "groupId": "OG001"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/2",
    "value": {
      "value": "65",
      "groupId": "OG002"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/3",
    "value": {
      "value": "6",
      "groupId": "OG003"
    }
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "remove",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/title",
    "value": "Overall Survival (OS) of MTD&#x2F;Phase II Patients"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/description",
    "value": "Measured from Day 1 of study drug administration to date of death due to any cause.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/populationDescription",
    "value": "Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/description",
    "value": "The number of patients with observed complete response [CR] or partial response [PR].\nPer Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), &gt;=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/populationDescription",
    "value": "Patients who received the dose level 3 MTD dose&#x2F;Phase II dose (Amrubicin -110 mg&#x2F;m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD&#x2F;phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
  },
  {
    "op": "replace",
    "path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/timeFrame",
    "value": "every 6 weeks until treatment discontinuation, up to 43 months"
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/description",
    "value": "All patients who received at least one dose of protocol treatment were followed for safety.\nAdverse events and serious adverse events were collected from the day of the first dose to 30 days after the last dose of the study medication and graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0"
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/title",
    "value": "Dose Level 1"
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/description",
    "value": "Amrubicin - 90 mg&#x2F;m^2 by intravenous (IV) every 21 days"
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAffected",
    "value": 1
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAtRisk",
    "value": 3
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAffected",
    "value": 3
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/eventGroups/1",
    "value": {
      "id": "EG001",
      "title": "Dose Level 2",
      "description": "Amrubicin - 100 mg&#x2F;m^2 by intravenous (IV) every 21 days",
      "otherNumAtRisk": 3,
      "otherNumAffected": 3,
      "seriousNumAtRisk": 3,
      "seriousNumAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/eventGroups/2",
    "value": {
      "id": "EG002",
      "title": "Dose Level 3 (MTD)&#x2F;Phase II",
      "description": "Amrubicin - 110 mg&#x2F;m^2 by intravenous (IV) every 21 days Includes patients treated at the MTD in Dose Level 3 phase 1 and in phase II",
      "otherNumAtRisk": 66,
      "otherNumAffected": 65,
      "seriousNumAtRisk": 66,
      "seriousNumAffected": 5
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/eventGroups/3",
    "value": {
      "id": "EG003",
      "title": "Dose Level 4",
      "description": "Amrubicin - 120 mg&#x2F;m^2 by intravenous (IV) every 21 days",
      "otherNumAtRisk": 6,
      "otherNumAffected": 6,
      "seriousNumAtRisk": 6,
      "seriousNumAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/7",
    "value": {
      "term": "NEUTROPHIL COUNT DECREASED",
      "stats": [
        {
          "groupId": "EG000",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG001",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG002",
          "numAtRisk": 66,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG003",
          "numAtRisk": 6,
          "numEvents": 1,
          "numAffected": 1
        }
      ],
      "organSystem": "Blood and lymphatic system disorders",
      "assessmentType": "SYSTEMATIC_ASSESSMENT",
      "sourceVocabulary": "CTCAE v 4.0"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/8",
    "value": {
      "term": "THROMBOCYTOPENIA",
      "stats": [
        {
          "groupId": "EG000",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG001",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG002",
          "numAtRisk": 66,
          "numEvents": 2,
          "numAffected": 1
        },
        {
          "groupId": "EG003",
          "numAtRisk": 6,
          "numEvents": 0,
          "numAffected": 0
        }
      ],
      "organSystem": "Blood and lymphatic system disorders",
      "assessmentType": "SYSTEMATIC_ASSESSMENT",
      "sourceVocabulary": "CTCAE v 4.0"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/seriousEvents/9",
    "value": {
      "term": "PULMONARY INFILTERATES",
      "stats": [
        {
          "groupId": "EG000",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG001",
          "numAtRisk": 3,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG002",
          "numAtRisk": 66,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG003",
          "numAtRisk": 6,
          "numEvents": 0,
          "numAffected": 0
        }
      ],
      "organSystem": "Respiratory, thoracic and mediastinal disorders",
      "assessmentType": "SYSTEMATIC_ASSESSMENT",
      "sourceVocabulary": "CTCAE v 4.0"
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 9,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 17,
      "numAffected": 6
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 39,
      "numAffected": 8
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numEvents",
    "value": 6
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAffected",
    "value": 2
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 126,
      "numAffected": 32
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 6,
      "numAffected": 3
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numEvents",
    "value": 7
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAffected",
    "value": 1
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 12,
      "numAffected": 3
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 130,
      "numAffected": 27
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 5,
      "numAffected": 3
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 7,
      "numAffected": 2
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 40,
      "numAffected": 21
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 5,
      "numAffected": 3
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 7,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 2,
      "numAffected": 2
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 39,
      "numAffected": 14
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 12,
      "numAffected": 6
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 16,
      "numAffected": 8
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 49,
      "numAffected": 15
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 13,
      "numAffected": 6
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 48,
      "numAffected": 18
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 2,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 26,
      "numAffected": 9
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 13,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 5,
      "numAffected": 5
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 13,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 24,
      "numAffected": 9
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 13,
      "numAffected": 12
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 9,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 5,
      "numAffected": 5
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numEvents",
    "value": 2
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAffected",
    "value": 1
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 49,
      "numAffected": 10
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 4,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 19,
      "numAffected": 7
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numEvents",
    "value": 5
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAffected",
    "value": 2
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 11,
      "numAffected": 2
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 203,
      "numAffected": 47
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 10,
      "numAffected": 4
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 4,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 16,
      "numAffected": 9
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numEvents",
    "value": 1
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAffected",
    "value": 1
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 15,
      "numAffected": 8
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 7,
      "numAffected": 4
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 9,
      "numAffected": 5
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 9,
      "numAffected": 3
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 83,
      "numAffected": 34
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 7,
      "numAffected": 3
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 1,
      "numAffected": 1
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 11,
      "numAffected": 9
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 3,
      "numAffected": 2
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 41,
      "numAffected": 8
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numEvents",
    "value": 6
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAffected",
    "value": 2
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 9,
      "numAffected": 2
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 82,
      "numAffected": 25
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 5,
      "numAffected": 4
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 58,
      "numAffected": 11
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 8,
      "numAffected": 3
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 87,
      "numAffected": 36
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 8,
      "numAffected": 5
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 17,
      "numAffected": 7
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 4,
      "numAffected": 2
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 49,
      "numAffected": 19
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 9,
      "numAffected": 5
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 5,
      "numAffected": 5
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 2,
      "numAffected": 1
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 26,
      "numAffected": 15
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 2,
      "numAffected": 2
    }
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numEvents",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAffected",
    "value": 0
  },
  {
    "op": "replace",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAtRisk",
    "value": 3
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/1",
    "value": {
      "groupId": "EG001",
      "numAtRisk": 3,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/2",
    "value": {
      "groupId": "EG002",
      "numAtRisk": 66,
      "numEvents": 11,
      "numAffected": 6
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/3",
    "value": {
      "groupId": "EG003",
      "numAtRisk": 6,
      "numEvents": 0,
      "numAffected": 0
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/otherEvents/40",
    "value": {
      "term": "PAIN",
      "stats": [
        {
          "groupId": "EG000",
          "numAtRisk": 3,
          "numEvents": 3,
          "numAffected": 2
        },
        {
          "groupId": "EG001",
          "numAtRisk": 3,
          "numEvents": 14,
          "numAffected": 2
        },
        {
          "groupId": "EG002",
          "numAtRisk": 66,
          "numEvents": 0,
          "numAffected": 0
        },
        {
          "groupId": "EG003",
          "numAtRisk": 6,
          "numEvents": 15,
          "numAffected": 4
        }
      ],
      "organSystem": "General disorders",
      "assessmentType": "SYSTEMATIC_ASSESSMENT",
      "sourceVocabulary": "CTCAE v 4.0"
    }
  },
  {
    "op": "add",
    "path": "/resultsSection/adverseEventsModule/timeFrame",
    "value": "every 3 weeks up to 43 months"
  }
]